| year | Average | Low | High | Change from close on 2022-04-22 |
| 2022 | $2.66 | $2.62 | $2.77 | -7.22 % |
| 2023 | $2.64 | $2.57 | $2.67 | -7.9 % |
| 2024 | $2.1 | $1.87 | $2.5 | -26.88 % |
| 2025 | $3.05 | $2.23 | $4.91 | 6.22 % |
Should you invest in Inovio stock?
Inovio Pharmaceuticals Inc quote is equal to 3.230 USD at 2022-03-01. Based on our forecasts, a long-term increase is expected, the "INO" stock price prognosis for 2027-02-26 is 9.137 USD. With a 5-year investment, the revenue is expected to be around +182.88%.
What is the Inovio stock price prediction for 2027-01-22?
Apr 16, 2022 · On average, they anticipate Inovio Pharmaceuticals' stock price to reach $12.40 in the next year. This suggests a possible upside of 398.0% from the stock's current price. View analysts' price targets for Inovio Pharmaceuticals or view top …
What is the upside for Inovio Pharmaceuticals'stock?
Jan 27, 2020 · Monday, January 27, 2020 09:56 AM | InvestorsObserver Analysts. Analysts who follow Inovio Pharmaceuticals Inc ( INO) on average expect it to rise 81.09% over the next twelve months. Those same analysts give the stock an average rating of Strong Buy. That average rating puts the stock higher than 79 of stocks, based on data compiled by InvestorsObserver.
What is the price targets for Inovio Pharmaceuticals (Invi)?
11 rows · For Inovio Pharmaceuticals stock forecast for 2025, 12 predictions are offered for each month of ...
See more
The Score for INO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal. INO is currently trading in the 30-40% percentile range relative to …
Is Inovio stock a buy or sell?
Is INO a Buy Sell or Hold?
...
Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 25.08% |
| 2 | Buy | 18.56% |
| 3 | Hold | 10.15% |
| 4 | Sell | 5.79% |
Is Inovio a shorted stock?
What is Nio price target?
Who owns Inovio Pharmaceuticals?
| Stockholder | Stake | Shares owned |
|---|---|---|
| SSgA Funds Management, Inc. | 10.49% | 23,267,928 |
| BlackRock Fund Advisors | 7.05% | 15,637,463 |
| The Vanguard Group, Inc. | 4.83% | 10,703,079 |
| D. E. Shaw & Co. LP | 2.70% | 5,985,533 |
Why is Ino down?
This can be attributed to the spread of the new Covid-19 variant - Omicron. Inovio is developing INO-4800 - its Covid-19 vaccine candidate, which is now in late stage clinical trials and it is still several months before it can hit the market, subject to regulatory approval.Dec 17, 2021
Is Ino short squeeze?
Is nikola shorted?
Why is Blnk shorted?
Who owns the most NIO stock?
| Stockholder | Stake | Shares owned |
|---|---|---|
| Baillie Gifford & Co. | 5.75% | 88,750,621 |
| BlackRock Fund Advisors | 2.60% | 40,093,147 |
| The Vanguard Group, Inc. | 2.40% | 36,994,474 |
| SSgA Funds Management, Inc. | 2.13% | 32,887,731 |
Will Ford stock continue to rise?
The automaker's stock rose 136% in 2021 and continues to rise in the new year, already up 21% so far in 2022. If you invested $10,000 in Ford's stock a year back, your investment would have risen to $25,630 as of this writing on January 17th.Jan 20, 2022
Is NIO at risk of delisting?
Is Inovio Pharmaceuticals a buy right now?
6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inovio Pharmaceuticals in the last twelve months. There are curre...
How has Inovio Pharmaceuticals' stock price been impacted by Coronavirus?
Inovio Pharmaceuticals' stock was trading at $8.37 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organ...
When is Inovio Pharmaceuticals' next earnings date?
Inovio Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, May 9th 2022. View our earnings forecast for In...
How were Inovio Pharmaceuticals' earnings last quarter?
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) released its earnings results on Tuesday, March, 1st. The biopharmaceutical company reported ($0.50) earn...
When did Inovio Pharmaceuticals' stock split? How did Inovio Pharmaceuticals' stock split work?
Inovio Pharmaceuticals shares reverse split on Friday, June 6th 2014. The 1-4 reverse split was announced on Friday, May 23rd 2014. The number of s...
What price target have analysts set for INO?
6 equities research analysts have issued 1-year price objectives for Inovio Pharmaceuticals' shares. Their forecasts range from $5.00 to $35.00. On...
Who are Inovio Pharmaceuticals' key executives?
Inovio Pharmaceuticals' management team includes the following people: J. Joseph Kim , President, Chief Executive Officer & Director Jacqueline E...
What is J. Joseph Kim's approval rating as Inovio Pharmaceuticals' CEO?
12 employees have rated Inovio Pharmaceuticals CEO J. Joseph Kim on Glassdoor.com . J. Joseph Kim has an approval rating of 82% among Inovio Pharm...
Who are some of Inovio Pharmaceuticals' key competitors?
Some companies that are related to Inovio Pharmaceuticals include Haemonetics (HAE) , NuVasive (NUVA) , Axonics (AXNX) , Beauty Health (SKIN) ,...
When did Inovio Pharmaceuticals reverse split?
Inovio Pharmaceuticals shares reverse split on Friday, June 6th 2014. The 1-4 reverse split was announced on Friday, May 23rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 5th 2014. An investor that had 100 shares of Inovio Pharmaceuticals stock prior to the reverse split would have 25 shares ...
When did the 1-4 reverse split happen?
The 1-4 reverse split was announced on Friday, May 23rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 5th 2014. An investor that had 100 shares of Inovio Pharmaceuticals stock prior to the reverse split would have 25 shares after the split.
INO : Inovio Pharmaceuticals stock forecast by Wall Street Analysts
The average Inovio Pharmaceuticals stock forecast from last 6 month is $7.0, and this show a -12.5% decrease in average from the prior price target of the each prediction. Also, this average forecast of $7.0 represents a -36.36% decrease from the past average forecast of $11.0, 6 months ago from 2 wall street analysts.
Frequently Asked Questions about Inovio Pharmaceuticals stock forecast
From Inovio Pharmaceuticals stock forecast , Inovio Pharmaceuticals (INO) stock cannot be a good investment choice. According to AI Pickup, the Inovio Pharmaceuticals stock price forecast for 2022 Mar. is $3.08052179823623
Inovio Pharmaceuticals Inc Stock Forecast
Is Inovio Pharmaceuticals Inc Stock Undervalued? The current Inovio Pharmaceuticals Inc [ INO] share price is $3.24. The Score for INO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Inovio Pharmaceuticals Inc Stock Price History
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INO is experiencing selling pressure, which indicates risk of future bearish movement.
Stock Predictions
Is Inovio Pharmaceuticals Inc stock public? Yes, Inovio Pharmaceuticals Inc is a publicly traded company.
Stock Price Forecast
The 8 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 35.00 and a low estimate of 6.00. The median estimate represents a +198.01% increase from the last price of 3.02.
Analyst Recommendations
The current consensus among 9 polled investment analysts is to Hold stock in Inovio Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Hold rating. Move your mouse over past months for detail
Inovio plans to tackle the omicron variant
Adria Cimino grew up with her nose in a book and a love of storytelling. By a twist of fate, she started her career writing about biotech in Boston and discovered that each company is the source of many fascinating stories.
Delivering DNA
First, let's talk about Inovio's good news. Last year, the U.S. Food and Drug Administration put Inovio's phase 2 and 3 trials on a partial clinical hold. Regulators had questions about the trial and the handheld device used to administer the vaccine candidate.
Will Inovio gain?
So, will any of these efforts result in gains for Inovio's shares? INO-4800 is closest to market, so any positive data from tests of that candidate against omicron could lift the stock in the coming weeks. The pan-COVID candidate could be big in the future.
